How Can Targeting the Tumor Microenvironment Improve Cancer Treatment?
Targeting the TME offers a promising avenue for cancer therapy. By disrupting the supportive interactions between cancer cells and their microenvironment, it may be possible to enhance the efficacy of existing treatments. For example, anti-angiogenic drugs aim to starve the tumor by inhibiting blood vessel formation. Similarly, modulating the immune landscape of the TME with immunotherapies can enhance the body's ability to fight cancer.
